Browser does not support script.
Browser does not support script.
Browser does not support script.
Browser does not support script.
Browser does not support script.
Browser does not support script.
Browser does not support script.
Browser does not support script.
Browser does not support script.
Clinical Research in Southampton
Southampton Children's Hospital
A
A
A
Text only
| Accessibility | Privacy and cookies
"Helpful, informative, polite and friendly staff put my mind at ease"
Patient feedback
Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us
You are here:
Home
>
Search results
Search
Browse site A to Z
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Search results
Go To Advanced Search
Search
You could also try:
beyond (184)
,
exceeding (120)
CytarabineSC
Description
Chemotherapy Protocol ACUTE MYELOID LEUKAEMIA CYTARABINE SC Regimen • Acute Myeloid Leukaemia – Cytarabine SC Indication • Acute myeloid
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/AML/CytarabineSC.pdf
Blinatumomab
Description
Chemotherapy Protocol Acute lymphoblastic leukaemia (ALL) Blinatumomab (3, 4 day) Regimen • ALL – Blinatumomab (3, 4 day schedule) Indication
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/ALL/Blinatumomab.pdf
Topotecan (1,8,15)
Description
Chemotherapy Protocol GYNAECOLOGICAL CANCER TOPOTECAN INTRAVENOUS (1, 8, 15) Regimen Ovary – Topotecan (1, 8, 15) Indication Second-line
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/Topotecan1815.pdf
Topotecan (1,8)
Description
Chemotherapy Protocol GYNAECOLOGICAL CANCER TOPOTECAN INTRAVENOUS (1, 8) Regimen Ovary – Topotecan (1, 8) Indication Second-line or subs
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/Topotecan18.pdf
Topotecan (1,2,3,4,5)
Description
Chemotherapy Protocol GYNAECOLOGICAL CANCER TOPOTECAN INTRAVENOUS (1, 2, 3, 4, 5) Regimen Ovary – Topotecan (1, 2, 3, 4, 5) Indication S
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/Topotecan12345.pdf
Etoposide PO
Description
Chemotherapy Protocol GYNAECOLOGICAL CANCER ETOPOSIDE ORAL Regimen Ovary-Etoposide Oral Indication Second line or subsequent treatment o
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/EtoposidePO.pdf
Cyclophosphamide PO
Description
Chemotherapy Protocol GYNAECOLOGICAL CANCER CYCLOPHOSPHAMIDE ORAL Regimen Ovary – Cyclophosphamide Oral Indication Relapsed/refractory o
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/CyclophosphamidePO.pdf
Panitumumab (21 day) Ver 1.1
Description
Chemotherapy Protocol COLORECTAL CANCER PANITUMUMAB (21 day) This regimen may require funding and is an unlicensed dose Regime
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Panitumumab21dayVer11.pdf
Everolimus Ver 1
Description
Chemotherapy Protocol PANCREATIC NEUROENDOCRINE CARCINOMA EVEROLIMUS This protocol may require funding Regimen PNET - Everolimus Indicat
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Endocrinecancer/Everolimus-Ver-1.pdf
Inhixa - patient information
Description
Your doctor has recommended that you take a medicine called 'Inhixa' to reduce your risk of blood clots. We hope this
Url
/Media/UHS-website-2019/Patientinformation/Pregnancyandbirth/Inhixa-patient-information.pdf
551
to
560
of
874
Previous
…
54
55
56
57
58
…
Next
Site policies
Report a problem with this page
Privacy and cookies
Site map
Translation
Last updated: 14 September 2019
Contact details
University Hospital Southampton NHS Foundation Trust
Tremona Road
Southampton
Hampshire
SO16 6YD
Telephone: 023 8077 7222
Useful links
Home
Getting here
What to do in an emergency
Research
Working here
Education
© 2014 University Hospital Southampton NHS Foundation Trust
Browser does not support script.
Browser does not support script.